When patients self-administer their medications, 60% do not take them as intended and over half of all patients are non-adherent. The resulting cost of non-adherence and non-optimized therapy is steep and everyone pays the price, from Pharmaceutical companies and payers to HCPs and their patients. The cost of non-adherence alone is US$300 billion per year with $188 billion of US pharma revenue lost.
The rules around healthcare engagement are now being rewritten with connected ecosystems and the ability to link self administered medications to disease management solutions. Technology has the potential to augment patient care, deliver value across the digital health ecosystem and deliver better outcomes for all stakeholders in a more connected future.
Aptar Pharma’s broad range of Digital Healthcare solutions come with trusted experience, empowering patients to take their health into their own hands and deliver value to HCPs, payers and our Pharma partners.